Raphamin for colds in children ages 3 to 12
Treatments studied
Part of Infections clinical trials.
This trial tests if Raphamin can safely treat common cold symptoms in children. It is for kids who have had cold symptoms for less than 24 hours and have a fever of at least 100°F with other symptoms like stuffy nose or sore throat.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child is between 3 and 12 years old
- Cold symptoms started less than 24 hours ago
- Has a fever of at least 100°F (37.8°C) and other cold symptoms
- No signs of severe illness needing hospitalization
- No other viral infections or bacterial infections like ear or sinus infections
- Parent or guardian signs a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a new cough syrup (Rengalin) helps children ages 6 months to 3 years with a dry cough from a viral cold. It aims to reduce cough severity and improve comfort for your child.
This study tests whether a medicine called Raphamin can safely and effectively treat acute bronchitis (a chest infection with cough) in adults. Raphamin may help reduce cough and breathing problems in the early stages of this condition.
This trial tests a new medicine called Raphamin for treating sudden sinus infection (acute rhinosinusitis) in adults. It compares the medicine to a placebo to see if it can reduce symptoms like facial pain and pressure when started within the first 2 days of illness.
This study looks at how rhinovirus (a common cold virus) affects children differently depending on their health and age. If your child is generally healthy or hospitalized with a breathing problem, they might be able to join.
This trial tests if antiviral medications can help adults with early respiratory syncytial virus (RSV) feel better faster. It is for people aged 18 to 64 who have had RSV symptoms for 4 days or less and have tested positive for the virus.
This study tests a medicine called AK0529 for babies and toddlers hospitalized with RSV. It aims to see if the drug helps them recover faster and is safe for this age group.
Hear when a new Acute Respiratory Viral Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.